SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-519117"
 

Sökning: id:"swepub:oai:DiVA.org:uu-519117" > The atypical sphing...

The atypical sphingolipid SPB 18:1(14Z);O2 is a biomarker for DEGS1 related hypomyelinating leukodystrophy

Hülsmeier, Andreas J. (författare)
Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland.
Toelle, Sandra P. (författare)
Univ Zurich, Univ Childrens Hosp Zurich, Dept Pediat Neurol, Zurich, Switzerland.
Bellstedt, Peter (författare)
Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland.
visa fler...
Wentzel, Christian, 1976- (författare)
Uppsala universitet,Barnonkologisk och neurologisk forskning
Bahr, Angela (författare)
Univ Zurich, Inst Med Genet, Zurich, Switzerland.
Kolokotronis, Konstantinos (författare)
Univ Zurich, Inst Med Genet, Zurich, Switzerland.
Hornemann, Thorsten (författare)
Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland.
visa färre...
Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland Univ Zurich, Univ Childrens Hosp Zurich, Dept Pediat Neurol, Zurich, Switzerland. (creator_code:org_t)
Elsevier, 2023
2023
Engelska.
Ingår i: Journal of Lipid Research. - : Elsevier. - 0022-2275 .- 1539-7262. ; 64:12
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Sphingolipids (SL) represent a structurally diverse class of lipids that are central to cellular physiology and neuronal development and function. Defects in the sphingolipid metabolism are typically associated with nervous system disorders. The C4dihydroceramide desaturase (DEGS1) catalyzes the conversion of dihydroceramide to ceramide, the final step in the SL de-novo synthesis. Loss of function mutations in DEGS1 cause a hypomyelinating leukodystrophy, which is associated with increased plasma dihydrosphingolipids (dhSL) and with the formation of an atypical SPB 18:1(14Z);O2 metabolite. Here, we characterize two novel DEGS1 variants of unknown significance (VUS), provide a structural model with a predicted substrate binding site, and propose a regulatory link between DEGS1 and fatty acid desaturase 3 (FADS3). Both VUS involve single amino acid substitutions near the C-terminus within conserved regions of the enzyme. Patient 1 (p.R311K variant) shows severe progressive tetraspasticity, intellectual disability, and epilepsy in combination with brain magnetic resonance imaging (MRI) findings, typical for DEGS1-related leukodystrophy. Patient 2 (p.G270E variant) presents with delayed psychomotor development, oculomotor apraxia, and a normal brain MRI. Plasma from the p.R311K carrier showed a significantly elevated dhSL species and the presence of SPB 18:1(14Z);O2, while the plasma SL profile for the p.G270E variant was not altered. This suggests the p.R331K variant is pathogenic, while the p.G270E appears benign. As an increase in dihydroSL species is also seen in other pathological disorders of the SL metabolism, the SPB 18:1(14Z);O2 seems to be a more specific biomarker to discriminate between pathogenic and benign DEGS1 variants.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Medicinsk genetik (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Medical Genetics (hsv//eng)

Nyckelord

Sphingolipids
DEGS1
hypomyelinating leukodystrophy
sphingolipidosis
HLD18
biomarker
SPT
FADS3
ceramide

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy